mifepristone has been researched along with gemcitabine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chen, C; Du, X; Eksterowicz, J; Fantin, VR; Huang, E; Huang, T; Jackson, E; Jahchan, N; Kawai, H; McGee, LR; Medina, JC; Rew, Y; Sun, D; Sutimantanapi, D; Waszczuk, J; Yan, X; Ye, Q; Zavorotinskaya, T; Zhou, H; Zhu, L | 1 |
| Balboa, L; Bruzzo, J; Chiarella, P; Fernández, GC; Isturiz, MA; Laborde, EA; Landoni, VI; Maglioco, A; Rearte, B; Ruggiero, RA | 1 |
1 review(s) available for mifepristone and gemcitabine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for mifepristone and gemcitabine
| Article | Year |
|---|---|
Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101).
Topics: Animals; Drug Discovery; Female; Hormone Antagonists; Humans; Mice; Ovarian Neoplasms; Rats; Receptors, Glucocorticoid; Swine; Swine, Miniature; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
Mifepristone (RU486) restores humoral and T cell-mediated immune response in endotoxin immunosuppressed mice.
Topics: Animals; Antigens, CD; Cyclophosphamide; Deoxycytidine; Forkhead Transcription Factors; Gemcitabine; Immunity, Cellular; Immunity, Humoral; Immunosuppression Therapy; Immunosuppressive Agents; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Mifepristone; Receptors, Glucocorticoid; T-Lymphocytes; T-Lymphocytes, Regulatory | 2010 |